title: Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer.
authors.affiliation: Taichung Veterans General Hospital and Chung Shan Medical University, Taiwan.
authors.forename: Gee-Chen
authors.initials: GC
authors.lastname: Chang
authors.forename: Tsung-Ying
authors.initials: TY
authors.lastname: Yang
authors.forename: Kun-Chieh
authors.initials: KC
authors.lastname: Chen
authors.forename: Ming-Chang
authors.initials: MC
authors.lastname: Yin
authors.forename: Ren-Ching
authors.initials: RC
authors.lastname: Wang
authors.forename: Yung-Chiou
authors.initials: YC
authors.lastname: Lin
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors; D005260:Female; D000077156:Gefitinib; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D010304:Paronychia / Q000139:chemically induced*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D004815:Epidermal Growth Factor; D011505:Protein-Tyrosine Kinases; D000077156:Gefitinib